Equity · Healthcare
HCAT
NASDAQHealth Catalyst (HCAT)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
- Market cap
- 172.1M USD
- Revenue, year to Dec 2025
- 311.1M USD
- EPS, diluted, year to Dec 2025
- −2.55 USD
- 52-week range
- 0.9994 USD – 4 USD
- Avg volume
- 436.7K
as of Jul 17, 2026
Have Health Catalyst (HCAT) insiders bought or sold shares recently?
In the 90 days to 11 Nov 2026, Health Catalyst insiders reported 1 open-market purchase and no sales (SEC Form 4).
Form 4, 90 days to 11 Nov 2026, newest reported trade 14 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 14 Sep 2026 | Kohl SimeonChief Executive Officer | Buy | 59,000 | 105K USD |
7 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 01 Oct 2026 | Reller TamiDirector | Award | 128,851 | |
| 14 Sep 2026 | Kohl SimeonChief Executive Officer | Award | 2,747,385 | |
| 10 Sep 2026 | Albert BenjaminCEO | Tax withheld | 35,244 | 59K USD |
| 01 Sep 2026 | Albert BenjaminCEO | Tax withheld | 321 | 547 USD |
| 01 Sep 2026 | Landry BenjaminGeneral Counsel | Tax withheld | 13,167 | 22K USD |
| 01 Sep 2026 | Alger JasonChief Financial Officer | Tax withheld | 17,973 | 31K USD |
| 01 Sep 2026 | Larson-Green JulieDirector | Award | 9,766 |
Which funds hold Health Catalyst (HCAT)?
5 of the 45 institutional funds we track reported a Health Catalyst position for the quarter ended 30 Jun 2026 — a combined 3.4M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Millennium Management | New position | 516,083 | 1.0M USD | |
| Citadel Advisors | New position | 453,214 | 902K USD | |
| AQR Capital Management | Trimmed | 376,586 | 749K USD | −30.7% |
| Renaissance Technologies | Added | 349,266 | 695K USD | +60.9% |
| Two Sigma Investments | New position | 13,713 | 27K USD |
What has been filed or recorded for Health Catalyst (HCAT)?
The filings we hold for Health Catalyst, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.53 USD | Revenue $56M |
| 30 Sep 2026 | Financials | Total assets | 237.4M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 145.6M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.55 USD | Revenue $70M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −1.53 USD | Revenue $71M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −2.55 USD | Revenue $311M |
| 31 Dec 2025 | Financials | Revenue | 311.1M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −178.0M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −2.55 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.32 USD | Revenue $76M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.59 USD | Revenue $81M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.35 USD | Revenue $79M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −1.15 USD | Revenue $307M |
What do people ask about Health Catalyst (HCAT)?
What is Health Catalyst’s market cap?172.1M
Health Catalyst is worth 172.1M USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.
What is Health Catalyst’s revenue?311.1M
Health Catalyst reported revenue of 311.1M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Health Catalyst insiders bought or sold shares recently?1 purchase
In the 90 days to 11 Nov 2026, Health Catalyst insiders reported 1 open-market purchase and no sales (SEC Form 4). A further 7 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Health Catalyst?5 of 45
5 of the 45 funds we track reported a Health Catalyst position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, Citadel Advisors and AQR Capital Management. See Funds
When did Health Catalyst last report earnings?0.53
Health Catalyst last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.53 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings